Investigators seeking to kopen CJC 1295 online for laboratory research require analytical-grade compounds supported by rigorous, lot-specific verification. CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analog extensively studied in preclinical models for its capacity to sustain elevated growth hormone (GH) and insulin-like growth factor 1 (IGF-1) levels. PX1 Research provides USA-manufactured CJC-1295 backed by independent HPLC, mass spectrometry, and endotoxin testing to guarantee assay reproducibility.
Investigators seeking to kopen CJC 1295 online for laboratory research require analytical-grade compounds supported by rigorous, lot-specific verification. CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analog extensively studied in preclinical models for its capacity to sustain elevated growth hormone (GH) and insulin-like growth factor 1 (IGF-1) levels. PX1 Research provides USA-manufactured CJC-1295 backed by independent HPLC, mass spectrometry, and endotoxin testing to guarantee assay reproducibility.
When research institutions plan to kopen CJC 1295 online, establishing stringent procurement criteria is vital to ensure experimental integrity. Research-grade CJC-1295 must be synthesized under controlled conditions to avoid micro-heterogeneity, truncated sequences, or residual solvent contamination. PX1 Research fulfills these requirements by offering fully characterized CJC-1295 synthesized in domestic facilities operating under strict quality management frameworks.
To maintain valid experimental controls, researchers must ensure every lot is paired with verified analytical documentation. PX1 Research supplies a comprehensive Certificate of Analysis (COA) per batch, detailing purity assays performed via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and accurate molecular mass verification using Electrospray Ionization Mass Spectrometry (ESI-MS). Acquiring validated reference standards through our research library hub supports accurate calibration and consistent data collection across cell culture and animal models.
CJC-1295 is a modified 29-amino acid tetrasubstituted peptide derivative of human growth hormone-releasing hormone (GHRH 1-29). The native GHRH sequence is inherently susceptible to rapid enzymatic cleavage in biological matrices, primarily by dipeptidyl peptidase IV (DPP-IV). To enhance structural stability and extend biological activity, four key amino acid substitutions were introduced at positions 2, 8, 15, and 27 (D-Ala2, Gln8, Ala15, and Leu27).
Preclinical studies indicate that these modifications significantly retard enzymatic degradation while maintaining high affinity for the GHRH receptor located on anterior pituitary somatotrophs. Upon receptor activation, CJC-1295 stimulates the G-protein coupled receptor pathway, initiating intracellular cyclic adenosine monophosphate (cAMP) accumulation and downstream protein kinase A (PKA) signaling. This cascade prompts the transcription and pulsatile secretion of endogenous growth hormone. Researchers investigating somatotropic axis regulation often evaluate these kinetics in comparison to other GHRH analogs.
A critical consideration when preparing to kopen CJC 1295 online is selecting between formulations with or without the Drug Affinity Complex (DAC). CJC-1295 with DAC incorporates a reactive maleimide derivative conjugated to the lysine residue at the C-terminus. In vivo preclinical models demonstrate that this maleimide group selectively forms a covalent bond with circulating endogenous albumin via a thioether linkage at the Cys34 position.
Albumin conjugation dramatically alters the pharmacokinetic profile of the peptide. By avoiding renal clearance and enzymatic breakdown, CJC-1295 DAC exhibits an extended half-life in rodent models—extending from minutes to several days. Conversely, CJC-1295 No DAC (frequently designated as Modified GRF 1-29) lacks the maleimide moiety, resulting in rapid clearance that more closely mimics physiological GHRH pulses. Understanding these distinct pharmacokinetic curves is essential when designing prolonged systemic exposures versus short-acting in vitro receptor binding assays.
In vitro data indicate that CJC-1295 selectively binds to GHRH receptors without activating collateral endocrine axes such as adrenocorticotropic hormone (ACTH), cortisol, or prolactin. This selective binding profile makes the compound an exceptionally clean tool for isolating somatotroph kinetics.
Rodent models demonstrate that extended exposure to CJC-1295 results in sustained elevation of basal growth hormone levels and a corresponding, dose-dependent rise in circulating insulin-like growth factor 1 (IGF-1). Unlike continuous infusion of recombinant GH, which can lead to receptor downregulation, CJC-1295 preserves physiological GH pulsatility, albeit at an elevated baseline. Researchers studying nitrogen retention, protein translation efficiency, and hepatic IGF-1 transcription utilize these properties to evaluate long-term metabolic outcomes.
The upregulation of the GH/IGF-1 axis via GHRH stimulation plays a central role in preclinical tissue regeneration models. Preclinical studies suggest that elevated systemic IGF-1 enhances satellite cell activation, accelerates myotube formation, and promotes extracellular matrix remodeling following mechanical injury. Consequently, CJC-1295 is frequently evaluated in musculoskeletal and connective tissue repair studies.
Additionally, animal studies demonstrate that CJC-1295 administration influences lipid metabolism and cellular energy homeostasis. Enhanced growth hormone signaling promotes lipolysis in adipose tissue by upregulating hormone-sensitive lipase activity, while simultaneously stimulating amino acid uptake in skeletal muscle. Laboratories exploring metabolic dysfunction, age-related somatopause models, and cellular senescence frequently source CJC-1295 to evaluate these physiological parameters.
Evaluating secretagogues within the somatotropic class requires analyzing receptor specificity, half-life, and downstream signaling intensity. For instance, Sermorelin represents the truncated 1-29 sequence of native GHRH without substitution modifications, presenting a very short biological half-life (~10–12 minutes) ideal for rapid pulse studies. In contrast, Tesamorelin features a hexenoyl moiety attached to the N-terminus of GHRH, providing enhanced stability specifically targeted toward hepatic lipolysis and visceral fat clearance models.
While GHRH analogs target the GHRH receptor, ghrelin receptor agonists like Ipamorelin act via the growth hormone secretagogue receptor (GHSR-1a). Preclinical research frequently utilizes combination protocols involving CJC-1295 and Ipamorelin to investigate receptor synergy. Dual activation of GHRH-R and GHSR-1a exhibits a synergistic effect on pituitary GH release far exceeding additive predictions. Detailed comparison data can be referenced in our analysis of CJC-1295 vs. Ipamorelin.
To ensure valid baseline measurements in sensitive bioassays, researchers searching to kopen CJC 1295 online must verify vendor quality control standards. Peptide purity should consistently exceed 98% as determined by RP-HPLC. Minor synthesis impurities—such as deletion sequences, incomplete deprotection byproducts, or oxidation states—can skew receptor affinity assays and lead to non-reproducible data.
Furthermore, quantitative endotoxin testing is imperative for all in vitro and animal research compounds. Bacterial endotoxins (lipopolysaccharides) induce non-specific inflammatory signaling, interleukin release, and cell mortality in culture. PX1 Research tests every batch using Limulus Amebocyte Lysate (LAL) assays, guaranteeing endotoxin levels strictly below <0.5 EU/mg. All analytical testing is conducted in ISO 17025 accredited laboratories to ensure absolute compliance with scientific standards.
CJC-1295 is supplied as a sterile, lyophilized cake to preserve chemical stability during transport and storage. Reconstitution protocols must be carefully tailored to the specific experimental design. For standard cell culture and biochemical assays, reconstituting with Bacteriostatic Water (0.9% benzyl alcohol) or Sterile Normal Saline is recommended. Benzyl alcohol acts as a preservative, preventing microbial proliferation over multiple sampling events.
When preparing stock solutions, gently trickle the solvent down the inner glass wall of the vial rather than spraying directly onto the peptide cake. Gentle swirl motion should be employed to achieve complete dissolution; mechanical agitation or vigorous shaking must be strictly avoided to prevent shear-induced peptide aggregation or tertiary structure disruption.
Lyophilized CJC-1295 retains structural integrity for extended periods when stored under controlled environment conditions. Unreconstituted vials should be kept sealed at -20°C for short-to-medium duration storage, or at -80°C for long-term repository storage, protected from light exposure. Avoid repeated freeze-thaw cycles, which degrade the peptide matrix.
Once solubilized, reconstituted CJC-1295 stock solutions should be stored at 2°C to 8°C and utilized within 14 to 28 days depending on the solvent system. If long-term storage of aliquots is required, prepare single-use working volumes in polypropylene microcentrifuge tubes and freeze immediately at -80°C to minimize degradation pathways such as deamidation or methionine oxidation.
PX1 Research is dedicated to supporting scientific advancement by supplying verified, domestic-grade research peptides. Every lot of CJC-1295 available through our inventory is manufactured in the USA within GMP-compliant facilities and thoroughly tested prior to distribution.
We maintain full supply chain transparency by attaching lot-specific COAs directly to product shipments and online documentation hubs. Orders are dispatched directly from our centralized fulfillment centers in California and Arizona with same-day shipping (Monday–Friday). Researchers looking to secure bulk orders or establish institutional supply lines can access optimized logistics through our wholesale lab portal or browse our full catalog of all research peptides.
What is CJC-1295 and how does it function in preclinical research?
CJC-1295 is a synthetic 29-amino acid tetrasubstituted analog of growth hormone-releasing hormone (GHRH). In preclinical models, it binds selectively to pituitary GHRH receptors, stimulating cyclic AMP signaling to promote the endogenous secretion of growth hormone and downstream IGF-1.
How can researchers verify the purity of CJC-1295 purchased online?
Purity is verified by reviewing lot-specific Certificates of Analysis (COAs) generated by independent ISO 17025 accredited laboratories. Look for Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) showing >98% purity, Electrospray Ionization Mass Spectrometry (ESI-MS) confirming molecular weight, and LAL endotoxin testing showing <0.5 EU/mg.
What is the primary operational difference between CJC-1295 DAC and No DAC?
CJC-1295 DAC contains a maleimide Drug Affinity Complex that covalently binds to circulating serum albumin in vivo, extending its biological half-life to several days. CJC-1295 No DAC (Modified GRF 1-29) lacks this complex, resulting in a short half-life (~30 minutes) that yields transient GH spikes.
Which solvents are recommended for reconstituting CJC-1295 in vitro?
For routine laboratory assays, reconstitute lyophilized CJC-1295 using sterile Bacteriostatic Water (0.9% benzyl alcohol) or Sterile Saline. Allow the solvent to flow down the inside vial wall and gently swirl until completely dissolved.
What endotoxin threshold is acceptable for CJC-1295 research applications?
To ensure cell culture viability and prevent non-specific immunological activation in animal models, research compounds must contain less than 0.5 Endotoxin Units per milligram (<0.5 EU/mg) as measured by quantitative LAL testing.
How should reconstituted CJC-1295 stock solutions be stored?
Reconstituted liquid solutions should be stored at 2°C to 8°C (refrigerated) and used within 14 to 28 days. For extended storage, divide the reconstituted solution into single-use aliquots and store at -80°C to avoid degradation from freeze-thaw cycles.
Does PX1 Research provide lot-traceable COAs for CJC-1295?
Yes. Every batch of CJC-1295 supplied by PX1 Research includes a lot-specific Certificate of Analysis derived from third-party HPLC, MS, and endotoxin analysis, ensuring absolute traceability and consistency across research studies.
Can CJC-1295 be combined with ghrelin receptor agonists in research models?
Yes. Preclinical studies frequently investigate co-administration of CJC-1295 with ghrelin receptor agonists such as Ipamorelin to evaluate signal synergy between GHRH-R and GHSR-1a pathways.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.